Treatment for HBV-MN Patients in Chinese: An Open Parallel Controlled Trial
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2010 by Nanchang University.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Nanchang University
Information provided by:
Nanchang University
ClinicalTrials.gov Identifier:
NCT01152060
First received: June 28, 2010
Last updated: NA
Last verified: May 2010
History: No changes posted
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | June 28, 2010 | ||||
| Last Updated Date | June 28, 2010 | ||||
| Start Date ICMJE | January 2010 | ||||
| Estimated Primary Completion Date | November 2010 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE | Not Provided | ||||
| Original Primary Outcome Measures ICMJE | Not Provided | ||||
| Change History | No Changes Posted | ||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Treatment for HBV-MN Patients in Chinese: An Open Parallel Controlled Trial | ||||
| Official Title ICMJE | an Open Parallel Clinical Trial in HBV-GN Patients | ||||
| Brief Summary | Lamivudine treatment for HBV-DNA negative HBV-GN patients. |
||||
| Detailed Description | lamivudine and predinisone treatment for HBV-DNA negative HBV-GN patients. |
||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Observational Model: Cohort Time Perspective: Prospective |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Retention: Samples Without DNA Description: not available |
||||
| Sampling Method | Probability Sample | ||||
| Study Population | HBV-MN patients with heavy proteinuria in adults; HBsAg or HBeAg positive; HBV-DNA negative |
||||
| Condition ICMJE |
|
||||
| Intervention ICMJE | Not Provided | ||||
| Study Group/Cohort (s) |
|
||||
| Publications * | Xu G, Duang Z, Wu X, Zou H, Fang X, Tu W. Treatment of hepatitis B virus-associated membranous nephritis patients in Chinese: an open parallel controlled trial. Clin Chem Lab Med. 2011 Jun;49(6):1077-8. Epub 2011 Mar 17. No abstract available. | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Active, not recruiting | ||||
| Estimated Enrollment ICMJE | 10 | ||||
| Estimated Completion Date | November 2010 | ||||
| Estimated Primary Completion Date | November 2010 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years to 60 Years | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | Not Provided | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01152060 | ||||
| Other Study ID Numbers ICMJE | NCT00100504 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | ethics committee of Nanchang University, second affiliated hospital | ||||
| Study Sponsor ICMJE | Nanchang University | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | Nanchang University | ||||
| Verification Date | May 2010 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||